Cytiva delivers modular biologics factory to Lonza

The overall project was completed within its expected time range despite COVID-19 restrictions

picture of

Breaking News

Maynards to manage asset dispersal at former Avonmouth pharma site

Recently the company completed the dispersal of the complete contents of Recipharm’s Ashton-under-Lyne pharmaceutical ...

Datwyler expands CSR policies to assist COVID-19 efforts

The company’s CSR program also takes on three additional investments which include yearly donations to improve local ...

Cytiva delivers modular biologics factory to Lonza

The overall project was completed within its expected time range despite COVID-19 restrictions

The promise, challenge and evolution of cell and gene therapy

Cell and gene therapy treatments offer the hope of a cure for diseases that would otherwise result in a lifetime of ...

Cognate plans manufacturing expansion in US and Europe

Build-out of the commercial manufacturing location will begin in 2021 with the goal of coming online as quickly as ...

Abzena takes modular approach to biologics suites

This expansion has been driven by an increase in customer demand for commercial-scale 2000L single-use bioreactors ...

Drug dose delivery development, manufacturing and commercialisation trends: part II

In the wake of patient-centricity in the pharmaceutical industry, drug delivery technologies have emerged as a central ...

Hovione launches formulation screening service

The service aims to enable fast progress to clinical supplies and minimal formulation changes before commercialisation

Recipharm signs manufacturing agreement with Enzymatica

ColdZyme is intended to treat and alleviate common cold and has already been launched in about 30 countries across ...

Packaging prefilled syringes: solving the sterility conundrum

What’s the key to ensuring sterility when packaging prefilled syringes?

Navigating the sea change of pharmaceutical outsourcing: part II

After what has oft-been described as an unprecedented period of turbulence in almost every aspect of our everyday lives, ...

Navigating the sea change of pharmaceutical outsourcing: part I

After what has oft-been described as an unprecedented period of turbulence in almost every aspect of our everyday lives, ...

Fujifilm invests $2bn in American biopharmaceutical facility

Beyond fiscal year ending March 2026, Fujifilm aims for this latest investment to boost the annual growth rate of its ...

Recipharm and Moderna sign fill-finish agreement

Subject to regulatory approval of the vaccine in relevant countries outside of the US, supply is expected to commence ...